Thomson Reuters Integrity℠ provides researchers with reliable, detailed information, from the perspective of a scientist, across multiple disciplines to support successful drug research and development.
Updated daily, its expertly refined drug information is integrated in a single, flexible resource that can help to drive innovation and support earlier decision-making.
The Biomarkers Module of Thomson Reuters IntegritySM provides a wealth of reliable, high-quality, continually updated information supporting biomarker research at every stage of drug R&D
Enhance your Cortellis Competitive Intelligence subscription with access to the world’s most comprehensive Broker Research reports.
Newport Premium™ (for Generics) Newport Premium™ (for Innovators) are used to find qualified sources of active ingredients. Newport products are now used by more than 350 companies operating in more than 50 countries around the world.